VKTX Viking Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 29, 2026
$29.94
· of 52w range
· above low
· to high
$26.8952w low
$43.1552w high
Market Cap (MRQ)
$3.49B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Revenue (TTM)
$0
your badges
52W Range
$27–$43
Analyst Rating
BUY
Price Target
$95
P/E
-6.4
ROE
-88.9%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
VKTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$29.94
Market Cap (MRQ)
$3.49B
P/E (TTM)
-6.4
EPS (TTM)
$-4.67
Revenue (TTM)
$0
ROE (TTM)
-88.9%
52W Range
$27–$43
VKTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02016-12-31 → 2025-12-31
EPS$-3.192021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | VKTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -6.45Y avg ≈-17.6 | ≈-17.6 | · | · | |
| P/B (MRQ) | 8.65Y avg ≈4.7 | ≈4.7 | 4.0 | Overvalued | |
| Price / Cash Flow | -12.35Y avg ≈-22.8 | ≈-22.8 | · | · | |
| Price / Tangible Book | 5.45Y avg ≈4.7 | ≈4.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | VKTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA (TTM) | -79.2%5Y avg ≈-30.7% | ≈-30.7% | -17.4% | Weak | |
| ROE (TTM) | -88.9%5Y avg ≈-32.9% | ≈-32.9% | -29.1% | Weak | |
| ROIC | -61.6% | · | -14.3% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | VKTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.75Y avg ≈18.6 | ≈18.6 | 9.0 | Low liquidity | |
| Quick Ratio | 2.25Y avg ≈2.1 | ≈2.1 | 4.0 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | VKTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.0 | ≈0.0 | 0.3 | Weak | |
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-23.1%
Next Report
Oct 20, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 21, 2026 | $-1.10 | $-1.27 | 13.5% |
| March 31, 2026 | $-1.37 | $-1.03 | -32.5% | |
| Dec. 31, 2025 | $-1.38 | $-0.91 | -51.3% | |
| Sept. 30, 2025 | $-0.81 | $-0.69 | -17.2% | |
| June 30, 2025 | $-0.58 | $-0.46 | -27.4% | |
| March 31, 2025 | $-0.41 | $-0.33 | -23.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.57 | $7.89 | $3.48 | $1.86 | $2.58 | $3.34 | $3.83 | $4.15 | $0.38 | $0.39 | $0.90 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.47 | $-0.81 | $-0.78 | $-0.63 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.44 | $0.24 | $0.55 | $0.47 | $0.34 | $0.40 | $0.12 | $0.35 | $0.25 | $0.15 | $0.08 | · | |
| EPS (TTM) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | · | 112,320,000 | 112,134,000 | 112,069,000 | · | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.50 | $4.33 | · | $6.34 | $7.08 | $7.54 | · | $8.18 | $8.31 | $8.47 | $3.68 | $3.86 | $1.69 | $1.97 | $2.15 | $2.36 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | |
| Cash Flow / Share | · | $-0.99 | · | · | · | $-0.47 | · | · | · | $-0.06 | · | · | $-0.31 | · | · | · | |
| Cash / Share | $1.08 | $1.02 | · | $0.89 | $0.30 | $0.34 | · | $0.45 | $0.40 | $1.77 | $0.37 | $0.69 | $0.23 | $0.38 | $0.21 | $0.16 | |
| EPS (TTM) | $-4.67 | $-4.15 | · | $-2.13 | $-1.54 | $-1.16 | · | $-0.92 | $-0.93 | $-0.92 | $-0.92 | $-0.90 | $-0.94 | $-0.81 | $-0.77 | $-0.74 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-535M | $-472M | · | $-237M | $-172M | $-128M | · | $-99M | $-97M | $-94M | $-81M | $-74M | $-72M | $-62M | $-59M | $-57M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -8.4 | -7.8 | · | -12.3 | -17.2 | -20.8 | · | -68.8 | -57.0 | -89.1 | -12.0 | -18.0 | -17.7 | -3.4 | -3.8 | -4.1 | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -12.0% | -12.8% | · | -8.1% | -5.8% | -4.8% | · | -1.5% | -1.8% | -1.1% | -8.3% | -5.5% | -5.7% | -29.8% | -26.6% | -24.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M |
| Diluted EPS | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 499 filers · $3.8B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
499
Value held
$3.8B
New positions
84
Exited positions
44
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 84 (+8 vs prior Q) | 44 (-25 vs prior Q) | 153 (-5 vs prior Q) | 133 (+4 vs prior Q) | +5.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $351,254,252 | 9,984,487 | 9.30% | Shares |
| FMR LLC | $247,157,830 | 6,335,756 | 6.54% | Shares |
| BlackRock, Inc. | $241,458,213 | 6,189,649 | 6.39% | Shares |
| STATE STREET CORP | $218,705,430 | 5,606,394 | 5.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $197,143,394 | 5,053,663 | 5.22% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174,931,100 | 4,484,263 | 4.63% | Shares |
| TWO SIGMA INVESTMENTS, LP | $153,598,520 | 3,937,414 | 4.07% | Shares |
| MORGAN STANLEY | $135,990,439 | 3,486,040 | 3.60% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113,382,565 | 2,906,500 | 3.00% | Call option |
| AMERIPRISE FINANCIAL INC | $84,108,797 | 2,156,083 | 2.23% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $81,865,360 | 2,097,981 | 2.17% | Shares |
| TWO SIGMA ADVISERS, LP | $74,906,241 | 2,129,228 | 1.98% | Shares |
| AMERICAN CENTURY COMPANIES INC | $70,844,186 | 1,816,050 | 1.88% | Shares |
| D. E. Shaw & Co., Inc. | $62,649,826 | 1,605,994 | 1.66% | Shares |
| DIADEMA PARTNERS LP | $47,623,408 | 1,220,800 | 1.26% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46,039,602 | 1,180,200 | 1.22% | Put option |
| CITADEL ADVISORS LLC | $43,773,121 | 1,122,100 | 1.16% | Call option |
| BNP PARIBAS FINANCIAL MARKETS | $38,296,117 | 981,700 | 1.01% | Shares |
| CITADEL ADVISORS LLC | $37,118,600 | 951,515 | 0.98% | Shares |
| GOLDMAN SACHS GROUP INC | $36,780,227 | 942,841 | 0.97% | Shares |
| UBS Group AG | $36,515,505 | 936,055 | 0.97% | Shares |
| JPMORGAN CHASE & CO | $36,387,793 | 915,185 | 0.96% | Shares |
| JANE STREET GROUP, LLC | $35,091,757 | 899,558 | 0.93% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31,846,477 | 816,367 | 0.84% | Shares |
| RAYMOND JAMES FINANCIAL INC | $30,999,667 | 794,660 | 0.82% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $28,557,153 | 732,047 | 0.76% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28,504,217 | 730,690 | 0.75% | Shares |
| Pictet Asset Management Holding SA | $26,640,280 | 682,909 | 0.71% | Shares |
| Vestal Point Capital, LP | $26,526,800 | 680,000 | 0.70% | Shares |
| NORTHERN TRUST CORP | $24,448,309 | 626,719 | 0.65% | Shares |
| CITADEL ADVISORS LLC | $23,530,832 | 603,200 | 0.62% | Put option |
| Eversept Partners, LP | $23,519,987 | 602,922 | 0.62% | Shares |
| BlackBarn Capital Partners LP | $23,406,000 | 600,000 | 0.62% | Shares |
| Jump Financial, LLC | $22,621,196 | 579,882 | 0.60% | Shares |
| ADAR1 Capital Management, LLC | $22,393,222 | 574,038 | 0.59% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $21,067,468 | 540,053 | 0.56% | Shares |
| JANE STREET GROUP, LLC | $20,870,350 | 535,000 | 0.55% | Call option |
| Connor, Clark & Lunn Investment Management Ltd. | $20,698,979 | 530,607 | 0.55% | Shares |
| Caption Management, LLC | $20,511,458 | 525,800 | 0.54% | Call option |
| TANG CAPITAL MANAGEMENT LLC | $19,505,000 | 500,000 | 0.52% | Shares |
| MILLENNIUM MANAGEMENT LLC | $19,433,690 | 498,172 | 0.51% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $19,290,796 | 494,509 | 0.51% | Shares |
| Point72 Asset Management, L.P. | $18,463,745 | 473,308 | 0.49% | Shares |
| Clearbridge Investments, LLC | $17,350,907 | 444,781 | 0.46% | Shares |
| DIADEMA PARTNERS LP | $17,234,930 | 441,808 | 0.46% | Shares |
| BLAIR WILLIAM & CO/IL | $16,258,035 | 416,766 | 0.43% | Shares |
| Bank of New York Mellon Corp | $15,909,848 | 407,840 | 0.42% | Shares |
| ExodusPoint Capital Management, LP | $15,346,650 | 393,000 | 0.41% | Call option |
| BANK OF AMERICA CORP /DE/ | $14,971,064 | 383,775 | 0.40% | Shares |
| Walleye Trading LLC | $14,964,236 | 383,600 | 0.40% | Call option |
Company insiders 17 insiders · 9 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | July 29, 2026 S | 2,572,441 | 0 | 6 | $-14,005,897 |
| Greg Zante | Chief Financial Officer | July 29, 2026 S | 212,204 | 0 | 6 | $-2,823,737 |
| Marianna Mancini | Chief Operating Officer | July 29, 2026 S | 422,760 | 0 | 6 | $-2,727,473 |
| Michael Dinerman | Chief Operating Officer | May 4, 2015 C | 694,116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | June 1, 2026 A | · | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | March 10, 2026 P | 4,475 | 1 | 0 | $149,912 |
| Michael Morneau | VP, Finance and Administration | Jan. 19, 2021 F | 116,062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | Jan. 3, 2019 A | 141,063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | May 4, 2016 F | 160,836 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | Director | Aug. 1, 2026 A | 6,333 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | Director | Jan. 2, 2026 A | 4,390 | 0 | 0 | $0 |
| Lawson Macartney | Director | Jan. 2, 2026 A | 51,115 | 0 | 0 | $0 |
| Charles A Rowland Jr | Director | Jan. 2, 2026 A | 33,150 | 0 | 1 | $-2,134,200 |
| Matthew J Singleton | Director | Jan. 2, 2026 A | 12,650 | 0 | 0 | $0 |
| Matthew W Foehr | Director | Jan. 2, 2026 A | 135,186 | 0 | 1 | $-561,760 |
| Stephen W Webster | Director | Jan. 2, 2020 A | 8,000 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | 10% owner | Aug. 26, 2020 S | 5,819,383 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 45 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0.78% | 121,599 NS | July 31, 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.74% | 10,811 NS | July 31, 2026 | N-PORT |
| ESSC · Strategy Shares | 0.31% | 3,463 NS | July 31, 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0.22% | 1,661 NS | July 31, 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.15% | 4,217 NS | July 31, 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0.15% | 69,539 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.14% | 29,780 NS | July 31, 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.12% | 1,464,336 SH | Aug. 19, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 23,527 SH | Oct. 2, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.06% | 330,703 SH | Aug. 19, 2026 | Daily |
| IYH · iShares Trust | 0.06% | 66,102 SH | Sept. 11, 2026 | Daily |
| ESML · iShares Trust | 0.06% | 50,114 SH | Sept. 11, 2026 | Daily |
| ISCG · iShares Trust | 0.05% | 16,143 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 52,319 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.05% | 60,016 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.05% | 1,332,828 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.05% | 2,530,231 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 37,316 SH | Oct. 2, 2026 | Daily |
| IWS · iShares Trust | 0.03% | 156,686 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.03% | 6,550 SH | Sept. 11, 2026 | Daily |
| IWR · iShares Trust | 0.03% | 462,379 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,501,108 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 19,254 SH | Aug. 19, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 63,630 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,458 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 48,216 NS | July 31, 2026 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.01% | 25,563 SH | Aug. 19, 2026 | Daily |
| IWD · iShares Trust | 0.01% | 234,063 SH | Sept. 11, 2026 | Daily |
| REVS · Columbia ETF Trust I | 0.01% | 922 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.01% | 46,707 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 158,911 SH | Sept. 11, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.01% | 9,430 NS | July 31, 2026 | N-PORT |
| IWB · iShares Trust | 0.00% | 73,105 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 28,131 SH | Sept. 10, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 1,106 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 9,683 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1,044 NS | July 31, 2026 | N-PORT |
| IWF · iShares Trust | 0.00% | 33,127 SH | Sept. 11, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 1,939 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 6,609 NS | July 31, 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 92,569 SH | Aug. 19, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 12,830 SH | Aug. 19, 2026 | Daily |
| ISCB · iShares Trust | · | 4,916 SH | Sept. 11, 2026 | Daily |
| ISCV · iShares Trust | · | 12,964 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 40,261 SH | Sept. 11, 2026 | Daily |
VKTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 26 analysts
BUY
Median target
$95.00
+217.3%
9 34.6%
Strong Buy
14 53.8%
Buy
3 11.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
19 analysts · 2026-09-30Mean target $94.82 +216.7%
← Below all targets
Current price $29.94
Low$38.00
Mean$94.82
High$125.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| LEGN | · | -26.8 | · | · | -29.1% | · |
| PBLS | · | · | · | · | · | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
Latest News Recent headlines mentioning this company
VKTX Stock Soars as Viking Therapeutics Announces Positive GLP-1 Trial Results
Yahoo Finance · 1 week, 3 days ago
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September
Nasdaq · 3 weeks, 2 days ago
2 Beaten-Down Stocks With Massive Upside Potential
Nasdaq · 2 months, 3 weeks ago
Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
Nasdaq · 3 months, 1 week ago
Is Viking Therapeutics Stock Going to $100?
Nasdaq · 3 months, 3 weeks ago
Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
Nasdaq · 3 months, 3 weeks ago
1 Reason This Biotech Stock Could Triple Before Year-End
Nasdaq · 6 months ago
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
Nasdaq · 6 months, 1 week ago
What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment
Yahoo Finance · 6 months, 2 weeks ago
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 29, 2026